Anythings possible, but at this point, its purely an untested hypothesis. Are there benefits
If you qualify for the program, they will send your prescription to an FDA registered 503a pharmacy
Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists

Examples of these drugs include: biguanides, such as: metformin (Glucophage) dipeptidyl peptidase-4 (DPP-4) inhibitors, such as: alogliptin (Nesina) linagliptin (Tradjenta) saxagliptin (Onglyza) sitagliptin (Januvia) glucagon-like peptide 1 (GLP-1) agonists, such as: dulaglutide (Trulicity) liraglutide (Victoza) lixisenatide (Adlyxin) semaglutide (Ozempic) sodium-glucose co-transporter 2 (SGLT2) inhibitors, such as: canagliflozin (Invokana) dapagliflozin (Farxiga) empagliflozin (Jardiance) ertugliflozin (Steglatro) sulfonylureas, such as: glipizide (Glucotrol) glyburide (DiaBeta, Glynase) thiazolidinediones (TZDs), such as: pioglitazone (Actos) rosiglitazone (Avandia) A sliding scale for diabetes is a chart that displays a dosage scale for insulin treatment